dabigatran has been researched along with Hematuria in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, ZL; Tang, ZY; Wang, Y; Yang, WL; Zhao, XY; Zheng, DX | 1 |
| Biederman, L; Brodsky, SV; Ivanov, I; Kerlin, BA; Medipally, A; Parikh, S; Rovin, B; Satoskar, AA; Xiao, M | 1 |
| Al Khalili, F | 1 |
| Bhatt, NR; Davis, NF; Flynn, RJ; Manecksha, RP; McDermott, T; Nolan, WJ; Thomas, AZ | 1 |
| Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T | 1 |
| Hagihara, K; Ikeda, M; Iwanari, S; Nishikawa, S; Saita, H; Shimada, H; Shimoda, S; Takeoka, H; Tanaka, M; Taniguchi, K | 1 |
| Balafa, O; Duni, A; Elisaf, MS; Kalaitzidis, RG; Liapis, G; Rapsomanikis, PK; Xiromeriti, S | 1 |
| Finsterer, J; Rakusan, S; Stöllberger, C; Wimpissinger, FT | 1 |
2 review(s) available for dabigatran and Hematuria
| Article | Year |
|---|---|
Incidence of Visible Hematuria Among Antithrombotic Agents: A Systematic Review of Over 175,000 Patients.
Topics: Age Factors; Anticoagulants; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematuria; Humans; Incidence; Male; Patient Safety; Prognosis; Risk Assessment; Rivaroxaban; Sex Factors; Warfarin | 2018 |
Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Dabigatran; Female; Glomerulonephritis, IGA; Hematuria; Humans; Renal Insufficiency, Chronic; Risk Factors | 2017 |
6 other study(ies) available for dabigatran and Hematuria
| Article | Year |
|---|---|
Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use.
Topics: Acute Kidney Injury; Administration, Oral; Anticoagulants; Dabigatran; Female; Hematuria; Humans; Middle Aged; Nephritis, Interstitial | 2022 |
Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity.
Topics: Animals; Anticoagulants; Creatinine; Dabigatran; Endothelial Cells; Glomerular Filtration Barrier; Hematuria; Kidney Diseases; Rats; Receptor, PAR-1 | 2022 |
[Incidence, investigation and long-term follow-up of macroscopic hematuria in patients treated with non vitamin K antagonist oral anticoagulant: Insight from a specialist cardiology clinic].
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Substitution; Factor Xa Inhibitors; Female; Follow-Up Studies; Hematuria; Humans; Kidney Calculi; Male; Neoplasms; Prostatic Hyperplasia; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban | 2017 |
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin | 2018 |
Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Dabigatran; Female; Glomerulonephritis, IGA; Hematuria; Humans; Kidney Glomerulus; Venous Thrombosis; Withholding Treatment | 2019 |
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bone Neoplasms; Brain Ischemia; Comorbidity; Dabigatran; Hematuria; Humans; Kidney Failure, Chronic; Leuprolide; Male; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Thrombophilia; Urinary Retention | 2012 |